Guest guest Posted October 30, 2010 Report Share Posted October 30, 2010 News 10 new results for hepatitis c Race Affects Hepatitis C Recurrence After Liver Transplant: StudyU.S. News & World ReportSATURDAY, Oct. 30 (HealthDay News) -- Hepatitis C patients who receive a liver from a white donor have significantly more aggressive recurrent hepatitis ...See all stories on this topic » Vertex, Merck Drugs Help More With Faster Cure for Hepatitis CBloombergBy Fay Cortez - Sat Oct 30 13:00:00 GMT 2010 Vertex Pharmaceuticals Inc. and Merck & Co. said their experimental drugs for hepatitis C cured more ...See all stories on this topic » Gilead's Investigational Hepatitis C Compounds GS 9190 and GS 9256 in ...MarketWatch (press release)"Patients with chronic hepatitis C urgently need new and better treatment options, particularly combination therapies involving antiviral drugs that employ ...See all stories on this topic » Achieving Sustained Viral Response for Patients with Recurrent Hepatitis C ...PR Newswire (press release)... clinical outcomes of patients posttransplant who underwent antiviral therapy for recurrent hepatitis C virus (HCV) infection of the liver graft. ...See all stories on this topic » Man with hepatitis C gets 2 yrs. for spitting on copChicago Sun-TimesA Chicago man with hepatitis C who spit in the mouth of a Burns Harbor, Ind., police officer was sentenced to two years in prison. S. Vasquez, 56, ...See all stories on this topic » Hepatitis C outbreak hits Becker, Mahnomen — Can be passed by sharing needlesDL-OnlineAn upward trend in the number of Hepatitis C cases reported in Becker and Mahnomen counties this year has drawn the attention of the Minnesota Department of ...See all stories on this topic » New Data From Phase 3 Studies Showed Superior SVR (Viral Cure) Rates Achieved ...MarketWatch (press release)Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) today announced new data from its Phase 3 studies of people with genotype 1 chronic hepatitis C who have ...See all stories on this topic » Donor race may impact recurrent hepatitis C in liver transplant patientsEurekAlert (press release)DETROIT – The race of liver donors may affect recurrent hepatitis C in patients after liver transplant, according to a study by Henry Ford Hospital. ...See all stories on this topic » Week-24 Interim Results From Phase 2b PILLAR Study to be Presented as Late ...PR Newswire (press release)TMC435, a hepatitis C protease inhibitor, dosed once daily (qd) is being developed jointly by Tibotec Pharmaceuticals and Medivir. ...See all stories on this topic » Merck's Investigational Medicine Boceprevir Achieved Significantly Higher SVR ...TheStreet.com... its investigational oral hepatitis C protease inhibitor, demonstrated significantly higher sustained virologic response (SVR) 1 rates in adult patients ...See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.